The week of 17 to 23 March 2026 will be remembered as the one where the humanoid spectacle received a mnemonic code. While the folklore of demonstrations — robots dancing, boxing, and doing backflips on camera — saturated the news feeds, three strictly monetary facts unfolded in sequence. Taken in isolation, each tells a story of success. Put together, they outline a single sequence: China is listing the show before the use.
On 20 March, embodied AI goes public
On 20 March 2026, the Shanghai Stock Exchange formally accepted the initial public offering application from Unitree Robotics (宇树科技) on the STAR Market (科创板). This is, at this stage, the first listing of an ‘embodied artificial intelligence’ (具身AI) company on the Chinese A-share market. The operation aims to raise approximately 4.2 billion yuan (around 610 million dollars).
The underlying figure is solid. Based on a minimum free float of 10%, the application implies an initial floor valuation of 42 billion yuan, or approximately 6.2 billion dollars. And the income statement follows suit: in 2025, Unitree achieved revenue of 1.708 billion yuan, up 335% year-on-year, for an adjusted net profit of approximately 590 to 600 million yuan. The gross margin on core activities hovers around 60% — among the highest in the global robotics sector. On paper, it is the story of a cash machine opening to the public.
The figure buried by the triumph: -71.7%
Except that the same prospectus contains a hard metric covered up by the growth narrative. The average selling price of a Unitree humanoid robot has collapsed by 71.7%: from 593,400 yuan in 2023 to 167,600 yuan in the third quarter of 2025. The drop is documented as the result of complete vertical integration — motors, reducers, mechanical structures, and control systems developed in-house.
The gap in interpretation is the whole point. The +335% revenue growth occupies the headlines; the -71.7% drop in unit price remains buried in the appendices. The stock swells while the unit deflates. One could see this as an assumed conquest strategy — prioritising volume, as consumer electronics did — or as a signal that humanoid hardware is commoditising faster than the valuation suggests. Both narratives coexist in the same document.
On 23 March, foreign capital enters via financing
Three days later, on 23 March, another Chinese manufacturer, RobotEra, closed a strategic round taking its valuation beyond 10 billion yuan. The round brings together sixteen national and international industrial investors. Among the new entrants: Gaocheng Capital, Singtel Innov8 (Singapore), Woori Venture Partners (South Korea), the CICC Porsche Fund, Samsung, China Fortune-Tech Capital, Fenghe Capital, and Wuxi Capital.
The geometry deserves to be named. Korean, Singaporean, and Samsung capital are entering Chinese humanoid robotics — but through the funding round, not through purchase orders. The funds are earmarked for technological iteration and scaling, with a priority deployment announced in e-commerce logistics, industrial manufacturing, and pharmaceutical distribution. Foreigners are financing the promise of use; they are not yet the customers.
The suspicion, sourced outside the press release
The question that press releases never ask remains: who is buying these robots, and for what purpose? Two independent analyses provide a convergent element of the answer. ChinaTalk argues that Unitree has risen to the status of favourite by meeting academic demand and orchestrating a particularly strong marketing campaign before the Chinese public, with many non-academic buyers deploying the machines ‘for the show’. The viral spectacle is presented there as instrumental to commercial and stock positioning, not as an isolated technical feat.
For its part, KraneShares recalls that Unitree was valued at around 1.7 billion dollars during a mid-2025 round and is targeting an IPO range of 3 to 7 billion dollars on the STAR Market — and notes that the media buzz generated on TikTok, Instagram, FOX Business, and Yahoo Finance supports the brand’s visibility in parallel with the operation. Two sources, outside the official dossier, pointing to the same mechanism: the viral feeds the valuation.
Who holds the theatre
Governance closes the demonstration. Unitree’s founder, Wang Xingxing (王兴兴), holds 23.82% of the capital but controls 68.78% of the voting rights, via a dual-class share mechanism. Nearly seven votes out of ten for less than a quarter of the shares: opening to the public does not dilute the hand that steers.
The financial backdrop is already populated with leading players. At the time of the application filing, Unitree’s shareholders include Tencent, Alibaba, Ant Group, Geely, and China Mobile, while the Meituan group (9.65% via three entities in concerted action), Sequoia China (7.11%), Jingwei Ventures (5.45%), and Shunwei Capital (4.42%) hold the main institutional positions.
A sequence, not a coincidence
The motif can then be read in one stroke. A first embodied AI listing accepted on 20 March; a unit price falling by 71.7% in the same prospectus; an internationalised round closed on 23 March; and, corroborated outside the press release, the finding that the spectacle is an asset. None of these facts, alone, says that China is listing the show before the use. Together, they write it. This week, the valuation received a ticker — and the hardware depreciated as the equity appreciated.